Loading...
•
Jun 30, 2023
Teladoc Q2 2023 Earnings Report
Teladoc Health's Q2 2023 results showcased revenue growth and improved profitability.
Key Takeaways
Teladoc Health reported a 10% year-over-year increase in revenue, reaching $652.4 million for the second quarter of 2023. The company's operating cash flow was $101.2 million, with a free cash flow of $64.6 million. Net loss was $65.2 million, or $0.40 per share, while adjusted EBITDA increased by 54% to $72.2 million.
Revenue increased by 10% year-over-year to $652.4 million.
Operating cash flow reached $101.2 million, and free cash flow was $64.6 million.
Net loss was $65.2 million, or $0.40 per share.
Adjusted EBITDA increased by 54% to $72.2 million.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Teladoc Health provides an outlook based on current market conditions and expectations. For the third quarter of 2023, the company expects revenue between $650 and $675 million and adjusted EBITDA between $72 and $82 million. Net loss per share is projected to be between ($0.50) and ($0.40), with approximately 86 million U.S. Integrated Care Members. For the full year 2023, revenue is expected to be between $2.6 and $2.675 billion, adjusted EBITDA between $300 and $325 million, and net loss per share between ($1.60) and ($1.25), with approximately 86 million U.S. Integrated Care Members.
Positive Outlook
- Revenue is expected to be between $650 and $675 million.
- Adjusted EBITDA is projected to be between $72 and $82 million.
- U.S. Integrated Care Members are expected to be approximately 86 million.
- Full year revenue is expected to be between $2.6 and $2.675 billion.
- Full year adjusted EBITDA is projected to be between $300 and $325 million.
Challenges Ahead
- Net loss per share is projected to be between ($0.50) and ($0.40).
- The outlook is based on current market conditions and expectations.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...